Looking into the current session, Thermo Fisher Scientific Inc. (NYSE:TMO) shares are trading at $576.38, after a 0.88% decrease. Over the past month, the stock decreased by 3.10%, but over the past year, it actually increased by 10.82%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.

A Look at Thermo Fisher Scientific P/E Relative to Its Competitors

The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued.

Thermo Fisher Scientific has a lower P/E than the aggregate P/E of 75.26 of the Life Sciences Tools & Services industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued.

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.